Journals in Applications of molecular genetics

Applied & Translational Genomics

ISSN: 2212-0661

Applied & Translational Genomics is a new open access biomedical journal providing a forum for publication and discussion of cutting edge research and new developments in applied and translational genomics, including information technologies that enable both advances in the field as well as the application of advances to clinical care and educational, ethical, economic, public health, citizen and policy issues pertinent to research advances. As such the Applied & Translational Genomics is a uniquely interdisciplinary journal. Further, it aims to publish new approaches to 'translational genomics', such as studies designed to probe the elasticity and dynamism of molecular processes.The Journal's mission is to enhance the knowledge, clinical adoption and discussion of applied and translational genomics worldwide. Its ethics mission is to enable global benefit sharing through the publication of articles, analyses and commentaries of researchers, clinicians, and patient populations situated throughout the world. The journal encourages submissions by authors in the developing world and to support their access to publishing, the Journal invites authors for whom processing fees represent a barrier, to contact the editor about our sliding fee scale policy.The remit of the journal is broad to provide wide coverage across applied genomics and translational genomic research. Subject areas include:AgribiotechnologyAgrigenomicsApplied biotechnology (clinical applications, laboratory development, support)Big data analyticsBiobankingBio informaticsClinical cytogenomics (molecular cytogenetics)Clinical genomicsClinical informaticsClinical nanotechnologyClinical sequencingCompanion diagnosticsData bankingDigital detection (such as digital PCR)Digital innovations (as related to genomicsEpigeneticsEducation and media (professional and public education; bio-information via online and social media resources)Exome sequencingEthical, legal and social issues in applied and translational genomicsFunctional genomicsHealth informaticsInterpretation softwareLab-on-a- chipNanotechnology related to genomicsNext generation genomics (in relation to health care)NutrigenomicsMicrochip technologies/implants (in relation to genomics)Pharmaceutical industry (new drugs, therapeutic devices, vaccines)PharmacogenomicsFunctional ProteomicsPersonalized MedicinePoint of care diagnosticsPopulation/public health genomicsPredictive analytics (in relation to genetics/genomics)Social innovations enabling adoption of point of care genomicsVirtual/remote digital technologies (in relation to applied genomics)Visualization of biological dataBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our https://www.elsevier.com/authors/author-servicesauthor services.Please see our https://www.elsevier.com/journals/applied-and-translational-genomics/2212-0661/guide-for-authorsGuide for Authors for information on article submission. If you require any further information or help, please visit our https://service.elsevier.com/app/home/supporthub/publishing/Support Center

Subscriptions

Biochimica et Biophysica Acta: Molecular Basis of Disease

ISSN: 0925-4439
5 Year impact factor: 5.5
Impact factor: 4.2

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiovascular diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunological diseasesInflammatory diseasesMetabolic diseasesMitochondrial diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computational (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descriptive or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparative Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.

Subscriptions

Cell Systems

ISSN: 2405-4712
5 Year impact factor: 11.1
Impact factor: 9

For more information go to http://www.cell.com/cell-systems Cell Systems was established in 2015 to provide a home at Cell Press for elegant work that addresses fundamental questions in systems biology. "Systems biology," as we broadly define it, is work that develops a rigorous understanding of any biological phenomenon where one plus one does not apparently equal two. Disciplines in the physical sciences have met this challenge for a long time, and we've found that our strongest papers tend to apply quantitative, inference-based approaches taken in physics, engineering, mathematics, and computer science to salient biological questions.We believe it's our responsibility to ensure that the next generation of scientists can begin their work on solid ground. Accordingly, we focus our review process on validity and scientific acuity, rather than more subjective feelings and opinions. We also believe that scientific transparency is of paramount importance. A study's structure and presentation should be candid and forthright (e.g. it should ensure fair comparisons; it should either use non-arbitrary cut-offs or clearly explained arbitrary cut-offs that do not affect outcomes; its data visualization choices should promote objective understanding; its limitations should not be obscured). Fundamentally good scientific practice also demands that studies be repeatable. We encourage authors to make their code and data FAIR?that is findable, accessible, interoperable, and reusable, as defined by the NIH data commons. Although it is too early to formally require that all studies we publish be FAIR, we consider that requirement annually.As editors, we hold ourselves to the same standards of transparency but also recognize that living up to those standards requires constant effort. Like all journals, Cell Systems is a work in progress. A collection of editorials that document our thoughts and their evolution can be found here. We are always happy to talk to you.Visit the Cell Press website for more information about Cell System- http://www.cell.com/cell-systems/home

Subscriptions

FEBS Letters

ISSN: 0014-5793

FEBS Letters is one of the world's leading journals in biochemistry and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, hypotheses and research letters that merit urgent publication.FEBS Letters offers: • Faster publication: − Accepted articles are published online in 3 days − The print version of the article is published in 3 to 5 weeks after acceptance • Full-text article disclosure in HTML and PDF formats • Articles in Press are included in PubMed • Easy online manuscript submission system • Transparent online peer review and manuscript tracking system • No page charges • Free color figuresSubject Coverage: The subject area of FEBS Letters is broad. It covers biochemistry (including protein chemistry, enzymology, nucleic acid chemistry, metabolism, and immunochemistry), structural biology, biophysics, computational biology (genomics, proteomics, bioinformatics), molecular genetics, molecular biology and molecular cell biology (signal transduction, intracellular traffic, regulation of cellular proliferation, cell-cell interactions) and systems biology. Studies on microbes, plants and animals at the molecular level are within the scope of FEBS Letters.Submitting Authors: Manuscripts can be submitted to FEBS Letters at: http://ees.elsevier.com/febsletters/

Subscriptions

Human Immunology

ISSN: 0198-8859
5 Year impact factor: 2.3
Impact factor: 3.1

Human Immunology publishes full-length, original, hypothesis-driven basic and clinical research articles as well as brief communications, reviews and editorials covering immunogenetics, transplantation immunology, autoimmunity, and immunity to infectious diseases in humans. It also publishes short population reports, which are tied to the allelefrequencies.net database, describing allele frequencies of HLA and KIR.The journal's scope includes understanding the genetic and functional mechanisms that distinguish human individuals in their immune responses to allografts, pregnancy, infections or vaccines as well as the immune responses that lead to autoimmunity, allergy or drug hypersensitivity. It also includes examining the distribution of the genes controlling these responses in populations.Research areas include: • Studies of the genetics, genomics, polymorphism, evolution, and population distribution of immune-related genes • Studies of the expression, structure and function of the products of immune-related genes • Immunogenetics of susceptibility to infectious and autoimmune disease, and allergy • The role of the immune-related genes in hematopoietic stem cell, solid organ, and vascularized composite allograft transplant • Histocompatibility studies including alloantibodies, epitope definition, and T cell alloreactivity • Studies of immunologic tolerance and pregnancy • T cell, B cell, NK and regulatory cell functions, particularly related to subjects within the journal's scope • Pharmacogenomics and vaccine development in the context of immune-related genesHuman Immunology considers immune-related genes to include those encoding classical and non-classical HLA, KIR, MIC, minor histocompatibility antigens (mHAg), immunoglobulins, TCR, BCR, proteins involved in antigen processing and presentation, complement, Fc receptors, chemokines and cytokines. Other immune-related genes may be considered.Human Immunology is also interested in bioinformatics of immune-related genes and organizational topics impacting laboratory processes, organ allocation, clinical strategies, and registries related to autoimmunity and transplantation.Original papers with new data will be given preference over uninvited reviews and meta- analyses.Original papers with new data will be given preference over uninvited reviews and meta- analyses. As the flagship scientific publication of the American Society for Histocompatibility and Immunogenetics (ASHI), Human Immunology is primarily directed to readers with an interest in histocompatibility, immunogenetics, transplantation, anthropology/population studies, HLA disease association and pharmacogenomics. These include basic and clinical scientists as well as histocompatibility laboratory professionals.

Subscriptions

Journal of Biotechnology

ISSN: 0168-1656
5 Year impact factor: 3.6
Impact factor: 4.1

The Journal of Biotechnology (J. Biotech.) offers publication for both full-length articles and short communications on a wide range of biotechnology-related topics. Also, review articles can be submitted if they are pre-approved by one of the editors. The journal will only accept submissions with novel scientific research results that are directly relevant to biotechnological systems and/or applications (for details, please see the list below). J. Biotech. has strict rules about plagiarism. Any submission that includes parts of already published material will be rejected. This includes any attempt to re-publish already published Materials and Methods paragraphs. The journal features a "one-pass review process," i.e., eligible submissions will be reviewed, and those that need improvements (either minor or major) can be resubmitted only once before the decision about whether to accept or reject is decided by the Chief Editor. All figures need to be submitted as high-resolution files during the initial submission. All articles must be written in English, and the quality of the English language will be one of the criteria during the review process.Main Scope of the Journal:Bioprocess engineeringSystem biology, synthetic microbiologyMetabolic engineering, microbial physiologyBiorefinery, biomass engineeringBiochemical enzyme/protein engineeringMetabolic engineeringMicrobial expression systemsBiocatalyst engineeringInsect cell-based modelsMultienzyme cascade reactionsPlant-based biotechnologyOutside of the Scope:Manuscripts lacking noveltyReview articles submitted without previous invitation/confirmation by an editorEnvironmental-related subjects, e.g., waste-water treatment, bioremediation, biodegradationReports on the cloning and/or expression of naturally occurring enzymes without direct biotechnological applicationResearch on natural products without biotechnological modificationToxicological researchPharmacological researchFood science-related research without biotechnological applicationEngineering articles that do not deal with the direct improvement of biotechnological processesGenome research, especially genome sequencing reportsBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Mitochondrion

ISSN: 1567-7249
5 Year impact factor: 4.2
Impact factor: 3.9

Official Journal of the Mitochondria Research Society Affiliated with the Japanese Society of Mitochondria Research and MedicineMitochondrion is a definitive, high profile, peer-reviewed international research journal. The scope of Mitochondrion is broad, reporting on basic science of mitochondria from all organisms and from basic research to pathology and clinical aspects of mitochondrial diseases. The journal welcomes original contributions from investigators working in diverse sub-disciplines such as evolution, biophysics, biochemistry, molecular and cell biology, genetics, pharmacology, toxicology, forensic science, programmed cell death, aging, cancer and clinical features of mitochondrial diseases.Mitochondrion includes: MitoMatters: Editorial and news of general interest invited by Editorial Office. Profiles and Perspectives: Invited by Editorial Office and written by senior investigators in the field. The Mito Mew: Editorial and news of general interest. Review Articles: Reviews of major importance in mitochondrial biology. These articles will be peer-reviewed. Articles may be of any length; however, unusually long articles should be discussed with the editor before submission. Fast Track Articles: Peer-reviewed, short studies that are refereed rapidly and published generally within 10 weeks. These papers should be a concise complete piece of work of special significance and timeliness and should not exceed 4 printed pages (i.e., 10 pages of double-spaced typescript, including tables and figures up to a total number of 4). Original Articles: Peer-reviewed, high-quality, concise research investigations that represent new and significant contributions to science. Letters to the Editor: Comments on papers published in the Journal and on other matters of interest to mitochondria researcher. Book Reviews: invited by the editorial office. Announcements and Calendar: Providing notices of forthcoming meetings, courses, and other events relevant to mitochondria researchers.

Subscriptions

Molecular Therapy

ISSN: 1525-0016
5 Year impact factor: 11.8
Impact factor: 12.1

Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2022 impact factor is 12.4.To accommodate the rapid growth of Molecular Therapy, articles will be submitted and published in one of the following subsections (for section editors, please see the editorial board page):Biomarker and therapeutic target identificationCell therapyClinical gene and cell therapiesEpigenome editingGenome editingImmunotherapyMolecular diagnostics and imagingNon-viral gene therapyRNA therapiesSmall-molecule therapiesVaccine developmentViral gene therapyVisit the Cell Press website for more information about Molecular Therapy - http://www.cell.com/molecular-therapy-family/home

Subscriptions

Non-coding RNA Research

ISSN: 2468-0540
Impact factor: 5.9

Non-coding RNA Research aims to publish high quality research and review articles on the mechanistic role of non-coding RNAs in all human diseases. This interdisciplinary journal will welcome research dealing with all aspects of non-coding RNAs-their biogenesis, regulation and role in disease progression. The focus of this journal will be to publish translational studies as well as well-designed basic studies with translational and clinical implications.The non-coding RNAs of particular interest will be microRNAs (miRNAs), small interfering RNAs (siRNAs), small nucleolar RNAs (snoRNAs), U-RNAs/small nuclear RNAs (snRNAs), exosomal/extracellular RNAs (exRNAs), Piwi-interacting RNAs (piRNAs) and long non-coding RNAs.Topics of interest will include, but not limited to:Regulation of non-coding RNAsTargets and regulatory functions of non-coding RNAsEpigenetics and non-coding RNAsBiological functions of non-coding RNAsNon-coding RNAs as biomarkersNon-coding RNA-based therapeuticsPrognostic value of non-coding RNAsPharmacological studies involving non-coding RNAsPopulation based and epidemiological studiesGene expression / proteomics / computational / pathway analysis-based studies on non-coding RNAs with functional validationNovel strategies to manipulate non-coding RNAs expression and functionClinical studies on evaluation of non-coding RNAsThe journal will strive to disseminate cutting edge research, showcasing the ever-evolving importance of non-coding RNAs in modern day research and medicine.Editorial Board

Subscriptions

Reproduction and Breeding

ISSN: 2667-0712

Reproduction and Breeding is an Open Access journal that provides an academic platform for communication within the field. We are seeking high-quality articles on theories and applications associated with reproduction and breeding in plants, animals, humans and other organisms. Submissions exploring many aspects of reproductive biology and breeding will be considered.These include, but are not limited to, the following:GeneticsDevelopmental biologyBiotechnologyBiochemistry and molecular biologyCell biologyHydrobiologyAnimal and plant biologyEndocrinologyPhysiologyHuman reproduction biology/physiologyWe welcome full length research papers, review articles, short communications, and other interactive and ancillary materials that are of special interest to the readers of the journal.Editorial Board

Subscriptions

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Applications of molecular genetics

Applied & Translational Genomics

Biochimica et Biophysica Acta: Molecular Basis of Disease

Cell Systems

FEBS Letters

Human Immunology

Journal of Biotechnology

Mitochondrion

Molecular Therapy

Non-coding RNA Research

Reproduction and Breeding